Translational Medicine

(Experimental Medicine, Modelling and Biomarker Development)

Translational medicine is one of the greatest hurdles in drug development processes, where costly and potentially disastrous mistakes can be made. TranScrip's experts are experienced in the identification of safe pathways and the execution of late preclinical and early clinical programmes to ease transition to full clinical development. They understand the pathogenesis of diseases, patient population characterisation and unmet medical needs and how these can be modelled in silico. They are also adept at analysing discovery and toxicology data and subsequent validation of novel targets in humans to map clinical development pathways. They are practised in prediction of treatment response (personalised healthcare), in interventional and non-interventional experimental medicine studies and technologies that will identify and characterise disease sub-populations and therapy-related biomarkers.